Fluvoxamine for outpatient management of COVID-19 to prevent hospitalization: a systematic review and meta-analysis

TC Lee, S Vigod, É Bortolussi-Courval… - JAMA network …, 2022 - jamanetwork.com
Importance Widely available and affordable options for the outpatient management of
COVID-19 are needed, particularly for therapies that prevent hospitalization. Objective To …

Randomised clinical trials in critical care: past, present and future

A Granholm, W Alhazzani, LPG Derde, DC Angus… - Intensive care …, 2022 - Springer
Randomised clinical trials (RCTs) are the gold standard for providing unbiased evidence of
intervention effects. Here, we provide an overview of the history of RCTs and discuss the …

Strategies for lung-and diaphragm-protective ventilation in acute hypoxemic respiratory failure: a physiological trial

J Dianti, S Fard, J Wong, TCY Chan, L Del Sorbo… - Critical Care, 2022 - Springer
Background Insufficient or excessive respiratory effort during acute hypoxemic respiratory
failure (AHRF) increases the risk of lung and diaphragm injury. We sought to establish …

Effect of intravenous or intraosseous calcium vs saline on return of spontaneous circulation in adults with out-of-hospital cardiac arrest: a randomized clinical trial

MF Vallentin, A Granfeldt, C Meilandt, AL Povlsen… - Jama, 2021 - jamanetwork.com
Importance It is unclear whether administration of calcium has a beneficial effect in patients
with cardiac arrest. Objective To determine whether administration of calcium during out-of …

[HTML][HTML] Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and …

AM Albuquerque, I Eckert, L Tramujas… - Clinical Microbiology …, 2023 - Elsevier
Background Randomized controlled trials (RCT) established the mortality reduction by
tocilizumab (Actemra), baricitinib (Olumiant), and sarilumab (Kevzara) in hospitalized COVID …

Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis

N Devasenapathy, A Chu, M Wong… - The Lancet Child & …, 2023 - thelancet.com
Background Atopic dermatitis is a prevalent condition in children and can be effectively
managed with medications such as topical calcineurin inhibitors (pimecrolimus or …

Association between type of fluid received prior to enrollment, type of admission, and effect of balanced crystalloid in critically ill adults: a secondary exploratory …

FG Zampieri, FR Machado, RS Biondi… - American Journal of …, 2022 - atsjournals.org
Rationale: The effects of balanced crystalloid versus saline on clinical outcomes for ICU
patients may be modified by the type of fluid that patients received for initial resuscitation …

An inhaled galectin-3 inhibitor in COVID-19 pneumonitis: a phase Ib/IIa randomized controlled clinical trial (DEFINE)

EE Gaughan, TM Quinn, A Mills, AM Bruce… - American Journal of …, 2023 - atsjournals.org
Rationale: High circulating galectin-3 is associated with poor outcomes in patients with
coronavirus disease (COVID-19). We hypothesized that GB0139, a potent inhaled …

[HTML][HTML] Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial

FW Hamilton, T Lee, DT Arnold, R Lilford… - International Journal of …, 2021 - Elsevier
Background Randomized trials are generally performed from a frequentist perspective,
which can conflate absence of evidence with evidence of absence. The RECOVERY trial …

Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis

FG Zampieri, AB Cavalcanti, GL Di Tanna… - The Lancet …, 2024 - thelancet.com
Background The effect of balanced crystalloids compared with that of saline in critically ill
patients overall and in specific subgroups is unclear. We aimed to assess whether use of …